MyFinsight
Home
Blog
About
Net sales
$70,382K
Gross profit
$50,764K
Canceled cashflow
$19,618K
Net income
$17,050K
(-31.22%↓ Y/Y)
Depreciation and
amortization
$2,662K
(-48.81%↓ Y/Y)
Stock-based compensation
$1,935K
(-51.50%↓ Y/Y)
Accrued interest
$1,078K
Provision for inventory
write-downs
$787K
(-23.59%↓ Y/Y)
Provision for credit
losses
$333K
(-1.19%↓ Y/Y)
Amortization of issuance
costs on convertible...
$224K
Foreign currency
transaction effect on income
-$74K
(-126.52%↓ Y/Y)
Canceled cashflow
$33,714K
Cost of sales
$19,618K
Net cash provided by
operating activities
$15,965K
(-45.57%↓ Y/Y)
Canceled cashflow
$8,178K
Selling expense
$12,845K
Administrative expense
$7,526K
Other (income)
expense, net
-$3,349K
Finance expense
$2,647K
Regulatory and clinical
expense
$2,037K
Marketing expense
$1,563K
Research and development
expense
$1,472K
Process engineering
expense
$1,338K
Management information
systems expense
$937K
Net (decrease)
increase in cash and cash...
-$226K
(-114.42%↓ Y/Y)
Canceled cashflow
$15,965K
Proceeds from short-term
marketable securities
$71,916K
Proceeds from stock
option exercises
$776K
(-74.74%↓ Y/Y)
Accounts payable and
other liabilities
-$4,135K
(-230.80%↓ Y/Y)
Prepaid expenses and
other assets
$2,401K
(243.26%↑ Y/Y)
Non-cash investment
income
$703K
Inventory and other
deferred costs
$543K
(-84.28%↓ Y/Y)
Accounts receivable
$396K
(-92.53%↓ Y/Y)
Net cash used in
investing activities
-$11,078K
(46.40%↑ Y/Y)
Canceled cashflow
$71,916K
Net cash used in
financing activities
-$5,052K
(36.87%↑ Y/Y)
Effect of exchange rate
changes on cash and cash...
-$61K
(-106.71%↓ Y/Y)
Canceled cashflow
$776K
Purchases of short-term
marketable securities
$80,568K
(351.39%↑ Y/Y)
Purchases of property and
equipment
$2,313K
(-15.12%↓ Y/Y)
Payments related to
acquisitions, net of cash...
$113K
(18.95%↑ Y/Y)
Common stock cash
dividend paid
$5,716K
(-36.75%↓ Y/Y)
Deferred payments for
acquisitions
$95K
(-93.37%↓ Y/Y)
Payment of withholding
taxes in connection...
$17K
(-97.19%↓ Y/Y)
Back
Back
Cash Flow
LEMAITRE VASCULAR INC (LMAT)
LEMAITRE VASCULAR INC (LMAT)
source: myfinsight.com